Scholars Central

ArticlePublished 2021

QbD Compliance need or Cognizance of Science

Authors: Nitin M Kadam R&D Formulation, Naari Pharmaceuticals Private Limited, India.

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Quality by Design – New paradigm in Pharmaceutical Product Life Cycle. QbD has stirred pharma world w.r.t. new product filings and compliance. Enforcement of QbD in pharmaceutical development and continuing with product life cycle management has brought out an increased no of 483s to the no of manufacturers including giant pharma companies. And also decreased no of approvals after QbD enforcement. In this era of competition, quality has been given prime magnitude; failure to meet such quality allied goals produces massive shift of company in share of market. Recent past years have witnessed this through no of 483s to big pharma giants. “Quality could be planned and most of quality deficit arises in the way process is planned and developed”, this thought gives foundation to the concept of quality by design (QbD).

Subjects

Surgery

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in British Journal of Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBritish Journal of Research
  • SubjectSurgery
  • BylineArticles whose byline prints “Nitin M Kadam R&D Formulation”
  • BylineArticles whose byline prints “Naari Pharmaceuticals Private Limited”
  • BylineArticles whose byline prints “India.”